U.S. flag

An official website of the United States government

GTR Home > Conditions/Phenotypes > Wilms tumor 1

Summary

PAX6-related aniridia occurs either as an isolated ocular abnormality or as part of the Wilms tumor-aniridia-genital anomalies-retardation (WAGR) syndrome. Aniridia is a pan ocular disorder affecting the cornea, iris, intraocular pressure (resulting in glaucoma), lens (cataract and lens subluxation), fovea (foveal hypoplasia), and optic nerve (optic nerve coloboma and hypoplasia). Individuals with aniridia characteristically show nystagmus and impaired visual acuity (usually 20/100 - 20/200); however, milder forms of aniridia with subtle iris architecture changes, good vision, and normal foveal structure do occur. Other ocular involvement may include strabismus and occasionally microphthalmia. Although the severity of aniridia can vary between and within families, little variability is usually observed in the two eyes of an affected individual. WAGR syndrome. The risk for Wilms tumor is 42.5%-77%; of those who develop Wilms tumor, 90% do so by age four years and 98% by age seven years. Genital anomalies in males can include cryptorchidism and hypospadias (sometimes resulting in ambiguous genitalia), urethral strictures, ureteric abnormalities, and gonadoblastoma. While females typically have normal external genitalia, they may have uterine abnormalities and streak ovaries. Intellectual disability (defined as IQ <74) is observed in 70%; behavioral abnormalities include attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, anxiety, depression, and obsessive-compulsive disorder. Other individuals with WAGR syndrome can have normal intellect without behavioral problems. [from GeneReviews]

Genes See tests for all associated and related genes

  • Also known as: BRCC2, BROVCA2, FACD, FAD, FAD1, FANCD, FANCD1, GLM3, PNCA2, XRCC11, BRCA2
    Summary: BRCA2 DNA repair associated

  • Also known as: DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1, GPC3
    Summary: glypican 3

  • Also known as: K-glypican, KPTS, GPC4
    Summary: glypican 4

  • Also known as: ASM, ASM1, BWS, D11S813E, LINC00008, MIR675HG, NCRNA00008, WT2, H19
    Summary: H19 imprinted maternally expressed transcript

  • Also known as: C11orf43, GRDF, IGF-II, PP9974, SRS3, IGF2
    Summary: insulin like growth factor 2

  • Also known as: AWT1, GUD, NPHS4, WAGR, WIT-2, WT-1, WT33, WT1
    Summary: WT1 transcription factor

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.